Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Aflac Incorporated reported second-quarter 2026 net earnings of $1.63 per diluted share and adjusted earnings of $1.75 per diluted share, extending momentum from the first quarter and reflecting continued execution across Japan and the U.S. In Japan, second-quarter sales declined 5.6% against a strong prior-year period that benefited from the Miraito cancer insurance launch.</li><li>However, year-to-date sales increased 7% and are expected to exceed full-year 2025 levels.</li><li>Growth was supported by newer products including Tsumitasu savings-type life insurance and Anshin Palette medical insurance.</li></ul>

Aflac Incorporated reported second-quarter 2026 net earnings of $1.63 per diluted share and adjusted earnings of $1.75 per diluted share, extending momentum from the first quarter and reflecting continued execution across Japan and the U.S. In Japan, second-quarter sales declined 5.6% against a strong prior-year period that benefited from the Miraito cancer insurance launch.However, year-to-date sales increased 7% and are expected to exceed full-year 2025 levels.Growth was supported by newer products including Tsumitasu savings-type life insurance and Anshin Palette medical insurance.

Aflac’s Next Big Catalyst — Japan Margins, Higher Investment Income & Capital Returns Converge!

Hedge Fund News, Information and Data, Hedge Fund Alpha

Hedge Fund Alpha

Hedge Fund News, Information and Data

We focus on hedge funds with a bias towards emerging managers, specifically fundamental long-short managers. We are known for a lot of insights and exclusives on hedge fund letters, coverage of industry conferences, and interviews with investors and interesting service providers.

Thematic (Sector/Industry)

<ul><li>The Sherwood Foundation is a private philanthropic organization based in Omaha, Nebraska, led by Susan Alice Buffett, the eldest daughter of Warren Buffett and the late Susan Thompson Buffett.</li><li>Buffett established the foundation in 1999, aiming to support organizations that are focused on improving the quality of life across Nebraska.</li><li>Special focus is set on grants that expand opportunities for “underserved communities”.</li></ul>

The Sherwood Foundation is a private philanthropic organization based in Omaha, Nebraska, led by Susan Alice Buffett, the eldest daughter of Warren Buffett and the late Susan Thompson Buffett.Buffett established the foundation in 1999, aiming to support organizations that are focused on improving the quality of life across Nebraska.Special focus is set on grants that expand opportunities for “underserved communities”.

Buffett Sherwood Foundation 2025 990 Filing: Revenue Climbs to $943 Million as Investment Portfolio 

<ul><li>Aflac Incorporated reported solid financial results for the first quarter of 2026, reflecting strategic execution in both its Japanese and U.S. markets.</li><li>The company achieved adjusted earnings per diluted share of $1.75, representing a 6.6% increase year-over-year excluding foreign currency effects.</li><li>Net earnings per diluted share stood at $1.98.</li></ul>

Aflac Incorporated reported solid financial results for the first quarter of 2026, reflecting strategic execution in both its Japanese and U.S. markets.The company achieved adjusted earnings per diluted share of $1.75, representing a 6.6% increase year-over-year excluding foreign currency effects.Net earnings per diluted share stood at $1.98.

Can Aflac’s Japan Product Push Offset Weakness In The U.S. Agent Channel?

<ul><li>Aflac Incorporated reported solid financial results for the fourth quarter and full year 2025, demonstrating steady operational performance in both its Japan and U.S. segments amidst a complex economic environment.</li><li>The company recorded net earnings per diluted share of $2.64 in Q4 and $6.82 for 2025, with adjusted earnings per diluted share of $1.57 and $7.49, respectively.</li><li>In Japan, Aflac Japan achieved a significant sales increase of 15.7% in the fourth quarter and 16% for the full year, driven primarily by the strong reception of Miraito, a cancer insurance product launched in March 2025, which saw a remarkable 35.6% sales uplift.</li></ul>

Aflac Incorporated reported solid financial results for the fourth quarter and full year 2025, demonstrating steady operational performance in both its Japan and U.S. segments amidst a complex economic environment.The company recorded net earnings per diluted share of $2.64 in Q4 and $6.82 for 2025, with adjusted earnings per diluted share of $1.57 and $7.49, respectively.In Japan, Aflac Japan achieved a significant sales increase of 15.7% in the fourth quarter and 16% for the full year, driven primarily by the strong reception of Miraito, a cancer insurance product launched in March 2025, which saw a remarkable 35.6% sales uplift.

Aflac’s U.S. Growth Story Is Changing—Group Benefits Are Surging While Core Sales Lag!

<ul><li>Aflac Incorporated's third-quarter 2025 earnings call reveals a company exhibiting both strengths and areas requiring attention.</li><li>The company's reported net earnings per diluted share were $3.08 with adjusted earnings per share at $2.49, reflecting a robust 15.3% year-over-year growth.</li><li>This result showcases Aflac's effective management in both their U.S. and Japan operations, bolstered by strong underwriting discipline and strategic product positioning.</li></ul>

Aflac Incorporated's third-quarter 2025 earnings call reveals a company exhibiting both strengths and areas requiring attention.The company's reported net earnings per diluted share were $3.08 with adjusted earnings per share at $2.49, reflecting a robust 15.3% year-over-year growth.This result showcases Aflac's effective management in both their U.S. and Japan operations, bolstered by strong underwriting discipline and strategic product positioning.

Aflac Incorporated: How Cross-Selling Miraito

United States

Aflac, Inc. is a general business holding company. The Company, through its subsidiaries, provides supplemental insurance to individuals in the United States and Japan.  Aflac's products include accident/disability plans, cancer expense plans, short-term disability plans, sickness and hospital indemnity plans, hospital intensive care plans, and fixed-benefit dental plans.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Aflac Inc (AFL US)

Aflac’s Next Big Catalyst — Japan Margins, Higher Investment Income & Capital Returns Converge!

Aflac Incorporated reported second-quarter 2026 net earnings of $1.63 per diluted share and adjusted earnings of $1.75 per diluted share,...

Baptista Research

Buffett Sherwood Foundation 2025 990 Filing: Revenue Climbs to $943 Million as Investment Portfolio

Buffett established the foundation in 1999, aiming to support organizations that are focused on improving the quality of life across Nebraska.

Hedge Fund Alpha

Can Aflac’s Japan Product Push Offset Weakness In The U.S. Agent Channel?

Aflac Incorporated reported solid financial results for the first quarter of 2026, reflecting strategic execution in both its Japanese and U.S....

Baptista Research

Aflac’s U.S. Growth Story Is Changing—Group Benefits Are Surging While Core Sales Lag!

Aflac Incorporated reported solid financial results for the fourth quarter and full year 2025, demonstrating steady operational performance in...

Baptista Research

Aflac Incorporated: How Cross-Selling Miraito

Aflac Incorporated's third-quarter 2025 earnings call reveals a company exhibiting both strengths and areas requiring attention. The company's...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)